Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pk Med currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is handled by 1 distinct examiner and is located within 1 distinct art unit. This concentration suggests a specific technical application within the pharmaceutical field. The alignment of the 1 pending office action within a single art unit indicates that the technology involved is specialized and fits clearly into one biotechnological classification at the patent office.
YU, HONG is the busiest examiner for this portfolio, with 1 pending office action assigned. Given that there is only 1 distinct examiner for the company, this examiner is responsible for all current prosecution activity. The alignment of 1 distinct art unit and 1 distinct examiner provides a clear point of contact for the company's pending matter. For practitioners, this means that the prosecution strategy can be tailored to the specific expectations and standards of this single reviewer within their respective art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, HONG | 1 | 31.1% | +5.7% |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPk Med has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Hong Yu has the most, with 1 of Pk Med's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
